Grant of Options

Collagen Solutions plc

("Collagen Solutions", the "Company" or the "Group")

15 July 2016

Grant of Options

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that options over 2,700,000 ordinary shares of 1p each in the Company ("Ordinary Shares") were granted on 14 July 2016 to Jamal Rushdy, Chief Executive Officer ("Options").

The Options have an exercise period of ten years from grant and have an exercise price per Option of 8.125p. The Options vest in full upon the closing middle market price per Ordinary Share exceeding 30p during the exercise period. The Options are equivalent to 1.6 per cent. of the Company's existing issued share capital.

- Ends -

Enquiries: